Cargando…
In vivo polarisation sensitive optical coherence tomography for fibrosis assessment in interstitial lung disease: a prospective, exploratory, observational study
INTRODUCTION: Endobronchial polarisation sensitive optical coherence tomography (EB-PS-OCT) is a bronchoscopic imaging technique exceeding resolution of high-resolution CT (HRCT) by 50-fold. It detects collagen birefringence, enabling identification and quantification of fibrosis. STUDY AIM: To asse...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414088/ https://www.ncbi.nlm.nih.gov/pubmed/37553184 http://dx.doi.org/10.1136/bmjresp-2023-001628 |
_version_ | 1785087270185861120 |
---|---|
author | Vaselli, Margherita Kalverda-Mooij, Kirsten Thunnissen, Erik Tanck, Michael W T Mets, Onno M van den Berk, Inge A H Annema, Jouke T Bonta, Peter I de Boer, Johannes F |
author_facet | Vaselli, Margherita Kalverda-Mooij, Kirsten Thunnissen, Erik Tanck, Michael W T Mets, Onno M van den Berk, Inge A H Annema, Jouke T Bonta, Peter I de Boer, Johannes F |
author_sort | Vaselli, Margherita |
collection | PubMed |
description | INTRODUCTION: Endobronchial polarisation sensitive optical coherence tomography (EB-PS-OCT) is a bronchoscopic imaging technique exceeding resolution of high-resolution CT (HRCT) by 50-fold. It detects collagen birefringence, enabling identification and quantification of fibrosis. STUDY AIM: To assess pulmonary fibrosis in interstitial lung diseases (ILD) patients with in vivo EB-PS-OCT using histology as reference standard. PRIMARY OBJECTIVE: Visualisation and quantification of pulmonary fibrosis by EB-PS-OCT. SECONDARY OBJECTIVES: Comparison of EB-PS-OCT and HRCT detected fibrosis with histology, identification of ILD histological features in EB-PS-OCT images and comparison of ex vivo PS-OCT results with histology. METHODS: Observational prospective exploratory study. Patients with ILD scheduled for transbronchial cryobiopsy or surgical lung biopsy underwent in vivo EB-PS-OCT imaging prior to tissue acquisition. Asthma patients were included as non-fibrotic controls. Per imaged lung segment, fibrosis was automatically quantified assessing the birefringent area in EB-PS-OCT images. Fibrotic extent in corresponding HRCT areas and biopsies were compared with EB-PS-OCT detected fibrosis. Microscopic ILD features were identified on EB-PS-OCT images and matched with biopsies from the same segment. RESULTS: 19 patients were included (16 ILD; 3 asthma). In 49 in vivo imaged airway segments the parenchymal birefringent area was successfully quantified and ranged from 2.54% (no to minimal fibrosis) to 21.01% (extensive fibrosis). Increased EB-PS-OCT detected birefringent area corresponded to increased histologically confirmed fibrosis, with better predictive value than HRCT. Microscopic ILD features were identified on both in vivo and ex vivo PS-OCT images. CONCLUSIONS: EB-PS-OCT enables pulmonary fibrosis quantification, thereby has potential to serve as an add-on bronchoscopic imaging technique to diagnose and detect (early) fibrosis in ILD. |
format | Online Article Text |
id | pubmed-10414088 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-104140882023-08-11 In vivo polarisation sensitive optical coherence tomography for fibrosis assessment in interstitial lung disease: a prospective, exploratory, observational study Vaselli, Margherita Kalverda-Mooij, Kirsten Thunnissen, Erik Tanck, Michael W T Mets, Onno M van den Berk, Inge A H Annema, Jouke T Bonta, Peter I de Boer, Johannes F BMJ Open Respir Res Interstitial Lung Disease INTRODUCTION: Endobronchial polarisation sensitive optical coherence tomography (EB-PS-OCT) is a bronchoscopic imaging technique exceeding resolution of high-resolution CT (HRCT) by 50-fold. It detects collagen birefringence, enabling identification and quantification of fibrosis. STUDY AIM: To assess pulmonary fibrosis in interstitial lung diseases (ILD) patients with in vivo EB-PS-OCT using histology as reference standard. PRIMARY OBJECTIVE: Visualisation and quantification of pulmonary fibrosis by EB-PS-OCT. SECONDARY OBJECTIVES: Comparison of EB-PS-OCT and HRCT detected fibrosis with histology, identification of ILD histological features in EB-PS-OCT images and comparison of ex vivo PS-OCT results with histology. METHODS: Observational prospective exploratory study. Patients with ILD scheduled for transbronchial cryobiopsy or surgical lung biopsy underwent in vivo EB-PS-OCT imaging prior to tissue acquisition. Asthma patients were included as non-fibrotic controls. Per imaged lung segment, fibrosis was automatically quantified assessing the birefringent area in EB-PS-OCT images. Fibrotic extent in corresponding HRCT areas and biopsies were compared with EB-PS-OCT detected fibrosis. Microscopic ILD features were identified on EB-PS-OCT images and matched with biopsies from the same segment. RESULTS: 19 patients were included (16 ILD; 3 asthma). In 49 in vivo imaged airway segments the parenchymal birefringent area was successfully quantified and ranged from 2.54% (no to minimal fibrosis) to 21.01% (extensive fibrosis). Increased EB-PS-OCT detected birefringent area corresponded to increased histologically confirmed fibrosis, with better predictive value than HRCT. Microscopic ILD features were identified on both in vivo and ex vivo PS-OCT images. CONCLUSIONS: EB-PS-OCT enables pulmonary fibrosis quantification, thereby has potential to serve as an add-on bronchoscopic imaging technique to diagnose and detect (early) fibrosis in ILD. BMJ Publishing Group 2023-08-08 /pmc/articles/PMC10414088/ /pubmed/37553184 http://dx.doi.org/10.1136/bmjresp-2023-001628 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Interstitial Lung Disease Vaselli, Margherita Kalverda-Mooij, Kirsten Thunnissen, Erik Tanck, Michael W T Mets, Onno M van den Berk, Inge A H Annema, Jouke T Bonta, Peter I de Boer, Johannes F In vivo polarisation sensitive optical coherence tomography for fibrosis assessment in interstitial lung disease: a prospective, exploratory, observational study |
title | In vivo polarisation sensitive optical coherence tomography for fibrosis assessment in interstitial lung disease: a prospective, exploratory, observational study |
title_full | In vivo polarisation sensitive optical coherence tomography for fibrosis assessment in interstitial lung disease: a prospective, exploratory, observational study |
title_fullStr | In vivo polarisation sensitive optical coherence tomography for fibrosis assessment in interstitial lung disease: a prospective, exploratory, observational study |
title_full_unstemmed | In vivo polarisation sensitive optical coherence tomography for fibrosis assessment in interstitial lung disease: a prospective, exploratory, observational study |
title_short | In vivo polarisation sensitive optical coherence tomography for fibrosis assessment in interstitial lung disease: a prospective, exploratory, observational study |
title_sort | in vivo polarisation sensitive optical coherence tomography for fibrosis assessment in interstitial lung disease: a prospective, exploratory, observational study |
topic | Interstitial Lung Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414088/ https://www.ncbi.nlm.nih.gov/pubmed/37553184 http://dx.doi.org/10.1136/bmjresp-2023-001628 |
work_keys_str_mv | AT vasellimargherita invivopolarisationsensitiveopticalcoherencetomographyforfibrosisassessmentininterstitiallungdiseaseaprospectiveexploratoryobservationalstudy AT kalverdamooijkirsten invivopolarisationsensitiveopticalcoherencetomographyforfibrosisassessmentininterstitiallungdiseaseaprospectiveexploratoryobservationalstudy AT thunnissenerik invivopolarisationsensitiveopticalcoherencetomographyforfibrosisassessmentininterstitiallungdiseaseaprospectiveexploratoryobservationalstudy AT tanckmichaelwt invivopolarisationsensitiveopticalcoherencetomographyforfibrosisassessmentininterstitiallungdiseaseaprospectiveexploratoryobservationalstudy AT metsonnom invivopolarisationsensitiveopticalcoherencetomographyforfibrosisassessmentininterstitiallungdiseaseaprospectiveexploratoryobservationalstudy AT vandenberkingeah invivopolarisationsensitiveopticalcoherencetomographyforfibrosisassessmentininterstitiallungdiseaseaprospectiveexploratoryobservationalstudy AT annemajouket invivopolarisationsensitiveopticalcoherencetomographyforfibrosisassessmentininterstitiallungdiseaseaprospectiveexploratoryobservationalstudy AT bontapeteri invivopolarisationsensitiveopticalcoherencetomographyforfibrosisassessmentininterstitiallungdiseaseaprospectiveexploratoryobservationalstudy AT deboerjohannesf invivopolarisationsensitiveopticalcoherencetomographyforfibrosisassessmentininterstitiallungdiseaseaprospectiveexploratoryobservationalstudy |